According to Harvard Bioscience's latest financial reports the company's current earnings are HK$97.73 Million. In 2023 the company made an earning of -HK$19.87 Million, an increase over its 2022 earnings that were of -HK$71.35 Million. The earnings displayed on this page is the company's Pretax Income.